A “steady stream” of big products liability verdicts have been won by plaintiffs lawyers against Johnson & Johnson recently, notes an article in The New Jersey Law Journal.
Shanin Specter and his team made it 2-0 against Johnson & Johnson in a case against vaginal mesh, a defective product that has caused permanent injury to women across the country. The latest verdict came on Wednesday as a jury in Philadelphia Common Pleas Court handed down a $13.5 million award – including $10 million in punitive damages — to a Toms River, NJ woman who had the plastic-like device surgically implanted in 2005 to relieve urinary incontinence. Instead, Sharon Carlino, now 58, suffered severe pain during sexual intercourse after the mesh eroded in her body.
In the wake of snowballing defective product lawsuits in Pennsylvania and nationwide against the manufacturers of various transvaginal surgical mesh brands, our defective device attorneys — five of whom also are doctors — want to reiterate the dangers (as stated by the federal government) associated with this particular product.
Less than a month after our attorneys won a defective surgical device lawsuit on behalf of our client, Patricia Hammons, lawyers elsewhere also landed a major victory against another transvaginal mesh manufacturer.
Last month’s $12.5 million verdict for a woman against Johnson & Johnson over its surgically implanted vaginal mesh product has grown by nearly $800,000 following a judge’s recent decision to add delay damages to the result.
PHILADELPHIA -- A jury today awarded $7 million in punitive damages against Johnson & Johnson for an Indiana woman injured by a surgically implanted vaginal mesh. The plaintiffs claimed the product was defective and that J&J knew and failed to warn doctors about its dangers.
Opening speeches are due to get underway tomorrow in courtroom 246 in City Hall in the first Philadelphia trial involving a device surgically implanted in women to treat organ prolapse, a device called transvaginal mesh. The case involves the Prolift made by Ethicon, Inc., a division of Johnson & Johnson.
A jury in Dallas handed down a $73.5 million verdict against a medical device maker in a lawsuit filed by a woman who suffered injuries as a result of a vaginal implant intended to treat incontinence. The verdict was handed down in Dallas against Boston Scientific, one of seven manufacturers facing thousands of lawsuits over vaginal mesh products. The plaintiff in the Texas case was a 42-year-old woman who suffered nerve damage and infections from the implant. Among companies facing lawsuits are C.R. Bard and Ethicon, a subsidiary of Johnson & Johnson.
The Food and Drug Administration has proposed stricter classifications on surgically implanted vaginal mesh devices. The new classification would place pelvic mesh devices in the “high risk” classification, moving it up from the “moderate risk” category. The more restrictive classification would require makers of the devices to submit clinical data to the FDA regarding the newly manufactured devices safety before approval is given.
In further news on the massive transvaginal mesh litigation … Lee Balefsky is now a member of the Plaintiffs’ Steering Committee involved in all cases nationwide. Balefsky, head of Kline & Specter’s Mass Tort Department, was also named as liasion counsel in the Philadelphia Mass Tort Pelvic Mesh program. Balefsky has a long history of obtaining large settlements in pharmaceutical cases, including his role in the $4.85 billion Vioxx settlement and the settlement involving the diet drug Fen-Phen.